Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS
· Delayed Price · Currency is USD
0.0530
+0.0005 (0.99%)
At close: Mar 6, 2026
PVCT Market Cap
PVCT has a market cap or net worth of $22.28 million as of March 6, 2026. Its market cap has decreased by -51.22% in one year.
Market Cap
22.28M
Enterprise Value
24.65M
Revenue
350.44K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since April 24, 2002, PVCT's market cap has increased from 4.32K to 22.28M, an increase of 515,477.02%. That is a compound annual growth rate of 43.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Finch Therapeutics Group | 21.28M |
| EOM Pharmaceuticals Holdings | 20.24M |
| Oncotelic Therapeutics | 18.82M |
| Anebulo Pharmaceuticals | 17.95M |
| Inhibitor Therapeutics | 17.43M |
| Harvard Apparatus Regenerative Technology | 30.77M |
| Zeo ScientifiX | 14.30M |
| HOOKIPA Pharma | 13.25M |